Answer
No drug–drug interactions are anticipated in humans with Relestat epinastine hydrochloride eye drops because systemic concentrations after ocular dosing are extremely low and epinastine is mainly excreted unchanged, indicating little metabolism, although no interaction studies have been performed.
Sources for this answer
- Relestat 0.5 mg/ml, eye drops, solutionAbbVie Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 16Document updated
Sources checked